Search Within

Jason Chih-Peng Chang

Formats
  1. Meeting Abstract (70)
  2. Journal Article (66)
  3. Review (3)
  4. Book Section (1)
  5. Editorial (1)
  6. Research Letter (1)
Groups
  1. Department of Pathology and Laboratory Medicine (142)
  2. Department of Medicine (93)
  3. Solid Tumor Oncology Division (91)
  4. GSK Faculty (88)
  5. Thoracic Oncology (84)
  6. Human Oncology and Pathogenesis Program (76)

More Groups

People
  1. Natasha Rekhtman (90)
  2. William Travis (72)
  3. Marc Ladanyi (64)
  4. Jennifer Sauter (43)
  5. Maria Arcila (39)
  6. Charles Rudin (37)

More People

Years
  1. 2025 (14)
  2. 2024 (19)
  3. 2023 (14)
  4. 2022 (20)
  5. 2021 (27)
  6. 2020 (20)

More Years

Publications
  1. Laboratory Investigation (30)
  2. Modern Pathology (22)
  3. Journal of Thoracic Oncology (21)
  4. Clinical Cancer Research (8)
  5. Journal of Clinical Oncology (7)
  6. Journal of Molecular Diagnostics (6)

More Publications

Publishers
  1. Nature Publishing Group (35)
  2. Elsevier Inc. (28)
  3. Nature Research (22)
  4. American Association for Cancer Research (16)
  5. American Society of Clinical Oncology (11)
  6. Elsevier Science, Inc. (6)

More Publishers

Results (142)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Diagnosis of thoracic SMARCA4-deficient undifferentiated tumor in cytology
    Journal Article

    Kezlarian, B.; Montecalvo, J.; Bodd, F. M.; Chang, J. C.; Riedel, E.; White, C.; Rekhtman, N.; Sauter, J. L.
    Cancer Cytopathology (2023)

    Fulltext@MSK | Save
  • Genomic profiling of unusual sclerosing pneumocytomas with severe cytologic atypia and/or distant metastasis
    Meeting Abstract

    Fanaroff, R.; Cohen, A.; Selbs, E.; Chang, J.; Travis, W.; Mata, D.; Yang, S. R.
    Laboratory Investigation (2023)

    Fulltext@MSK | Save
  • "Hepatoid" Lung carcinoma demystified: HepPar1/CPS1 expression in carcinomas with solid and granular morphology reflects high mitochondrial content and metabolic reprogramming accompanying STK11/KEAP1/SMARCA4 alterations and is unrelated to hepatocellular differentiation
    Meeting Abstract

    Febres-Aldana, C.; Vanderbilt, C.; Seshan, S.; Richards, A.; Frosina, D.; Jungbluth, A.; Kezlarian, B.; Bodd, F.; Quintanal-Villalonga, A.; Ladanyi, M.; more...
    Laboratory Investigation (2023)

    Fulltext@MSK | Save
  • Targeting NFE2L2/KEAP1 mutations in advanced NSCLC with the TORC1/2 inhibitor TAK-228
    Journal Article

    Paik, P. K.; Fan, P. D.; Qeriqi, B.; Namakydoust, A.; Daly, B.; Ahn, L.; Kim, R.; Plodkowski, A.; Ni, A.; Chang, J.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • IASLC Lung Cancer Staging Project: The new database to inform revisions in the ninth edition of the TNM classification of lung cancer
    Review

    Asamura, H.; Nishimura, K. K.; Giroux, D. J.; Chansky, K.; Hoering, A.; Rusch, V.; Rami-Porta, R.; Members of the IASLC Staging and Prognostic Factors Committee and of the Advisory Boards, and Participating Institutions
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Neurofibromatosis type 2-yes-associated protein and transcriptional coactivator with PDZ-binding motif dual immunohistochemistry is a reliable marker for the detection of neurofibromatosis type 2 alterations in diffuse pleural mesothelioma
    Journal Article

    Li, Y.; Yang, S. R.; Chen, Y. B.; Adusumilli, P. S.; Bialik, A.; Bodd, F. M.; Ladanyi, M.; Lopardo, J.; Offin, M. D.; Rusch, V. W.; more...
    Modern Pathology (2023)

    Fulltext@MSK | Save
  • Non-small cell lung carcinomas with diffuse coexpression of TTF1 and p40: Clinicopathological and genomic features of 14 rare biphenotypic tumours
    Journal Article

    Savari, O.; Febres-Aldana, C.; Chang, J. C.; Fanaroff, R. E.; Ventura, K.; Bodd, F.; Paik, P.; Vundavalli, M.; Saqi, A.; Askin, F. B.; more...
    Histopathology (2023)

    Fulltext@MSK | Save
  • Switching inhibitor class overcomes crizotinib resistance in a MET fusion-positive NSCLC with a novel acquired MET G1090A mutation
    Meeting Abstract

    Murciano-Goroff, Y. R.; Kannan, S.; Chang, J. C.; Benayed, R.; Blokhin, I.; Rekhtman, N.; Sisk, A. E.; Gibson, J.; Judka, L.; Kaplanis, L.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Splicing factor mutant lung cancers: A comprehensive molecular and clinicopathologic characterization
    Meeting Abstract

    Harada, G.; Falcon, C. J.; Santini, F. C.; Chang, J. C.; Yang, S. R.; Arcila, M. E.; Rekhtman, N.; Drilon, A.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Mechanisms of acquired resistance to TRK inhibitors
    Meeting Abstract

    Harada, G.; Choudhury, N. J.; Schram, A. M.; Rosen, E.; Murciano-Goroff, Y. R.; Falcon, C. J.; Wilhelm, C.; Kaplanis, L. A.; Liu, D.; Chang, J. C.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save